文献速递关节外科

全膝关节置换术前皮质类固醇或透明质酸注射的感染风险比较

Comparison of Infection Risk with Corticosteroid or Hyaluronic Acid Injection Prior to Total Knee Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

基于全国私人保险数据库的回顾性队列研究,纳入58,337例单侧初次全膝关节置换患者,比较术前1年内接受皮质类固醇或透明质酸注射与未注射者的假体周围关节感染风险。结果显示,术前≤3个月接受任一种注射均独立增加感染风险(皮质类固醇OR 1.21,p=0.014;透明质酸OR 1.55,p=0.029),而>3个月注射无风险增加,两种药物间及单次与多次注射间无显著差异。作者建议全膝关节置换术前3个月内避免这两种注射。

要点

  • 术前≤3个月接受皮质类固醇或透明质酸注射均独立增加假体周围关节感染风险。
  • 术前>3个月注射未增加感染风险。
  • 两种药物间及单次与多次注射间感染风险无显著差异。

核心结论

  • 全膝关节置换术前≤3个月接受皮质类固醇或透明质酸注射增加假体周围关节感染风险。
  • 两种药物间及多次与单次注射间感染风险无差异。
  • 基于这些数据,作者建议全膝关节置换术前3个月内避免这两种注射。

研究设计与样本

  • 回顾性队列研究,数据来自全国私人保险数据库,纳入单侧初次全膝关节置换患者。
  • 共58,337例患者接受全膝关节置换;3,249例(5.6%)术前≤1年接受透明质酸注射,16,656例(28.6%)接受皮质类固醇注射。
  • 排除术前≤1年接受两种注射的患者;结局为全膝关节置换术后≤6个月发生的假体周围关节感染。
  • 采用逻辑回归控制年龄、性别和合并症,比较无注射、皮质类固醇、透明质酸组间及单次与多次注射间的感染风险。
  • 证据等级:治疗性III级。

主要发现

  • 无注射组总体感染率为2.74%。
  • 多变量逻辑回归显示,术前≤3个月皮质类固醇注射的假体周围关节感染独立风险OR为1.21(p=0.014)。
  • 术前≤3个月透明质酸注射的假体周围关节感染独立风险OR为1.55(p=0.029)。
  • 术前>3个月注射未增加感染风险。
  • 直接比较皮质类固醇与透明质酸,以及单次与多次注射,均无显著差异(p>0.05)。

关键数值与推荐

  • 术前≤3个月皮质类固醇注射:OR 1.21,p=0.014。
  • 术前≤3个月透明质酸注射:OR 1.55,p=0.029。
  • 无注射组总体感染率2.74%。
  • 皮质类固醇与透明质酸直接比较及单次与多次注射比较均p>0.05。

临床怎么用

  • 作者基于数据建议全膝关节置换术前3个月内避免皮质类固醇和透明质酸注射。
  • 术前>3个月注射未显示感染风险增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies have shown that intra-articular injections ≤3 months before total knee arthroplasty increase the risk of periprosthetic joint infection. We are aware of no previous study that has differentiated the risk of periprosthetic joint infection on the basis of the type of medication injected. In addition, we are aware of no prior study that has evaluated whether hyaluronic acid injections increase the risk of infection after total knee arthroplasty. In this study, we utilized pharmaceutical data to compare patients who received preoperative corticosteroid or hyaluronic acid injections and to determine whether a specific injection type increased the risk of periprosthetic joint infection. METHODS: Patients undergoing unilateral primary total knee arthroplasty were selected from a nationwide private insurer database. Ipsilateral preoperative injections were identified and were grouped by medication codes for corticosteroid or hyaluronic acid. Patients who had received both types of injections ≤1 year before total knee arthroplasty were excluded. The outcome of interest was periprosthetic joint infection that occurred ≤6 months following the total knee arthroplasty. The risk of periprosthetic joint infection was compared between groups (no injection, corticosteroid, hyaluronic acid) and between patients who received single or multiple injections. Statistical comparisons were performed using logistic regression controlling for age, sex, and comorbidities. RESULTS: A total of 58,337 patients underwent total knee arthroplasty during the study period; 3,249 patients (5.6%) received hyaluronic acid and 16,656 patients (28.6%) received corticosteroid ≤1 year before total knee arthroplasty. The overall infection rate was 2.74% in the no-injection group. Multivariable logistic regression showed independent periprosthetic joint infection risk for both corticosteroid (odds ratio [OR], 1.21; p = 0.014) and hyaluronic acid (OR, 1.55; p = 0.029) given ≤3 months before total knee arthroplasty. There was no increased risk with injections >3 months prior to total knee arthroplasty. Direct comparison of corticosteroid and hyaluronic acid showed no significant difference (p > 0.05) between medications or between single and multiple injections. CONCLUSIONS: Preoperative corticosteroid or hyaluronic acid injection ≤3 months before total knee arthroplasty increased the risk of periprosthetic joint infection. There was no difference in infection risk between medications or between multiple and single injections. On the basis of these data, we recommend avoiding both injection types in the 3 months prior to total knee arthroplasty. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Richardson SS, Schairer WW, Sculco TP, et al. Comparison of Infection Risk with Corticosteroid or Hyaluronic Acid Injection Prior to Total Knee Arthroplasty. J Bone Joint Surg Am. 2019. PMID: 30653040. doi:10.2106/JBJS.18.00454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。